Elanco Animal Health Inc
NYSE:ELAN

Watchlist Manager
Elanco Animal Health Inc Logo
Elanco Animal Health Inc
NYSE:ELAN
Watchlist
Price: 23.8 USD 3.25% Market Closed
Market Cap: 11.8B USD

Elanco Animal Health Inc
Cash & Cash Equivalents

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Elanco Animal Health Inc
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Elanco Animal Health Inc
NYSE:ELAN
Cash & Cash Equivalents
$505m
CAGR 3-Years
3%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash & Cash Equivalents
$8.4B
CAGR 3-Years
15%
CAGR 5-Years
-5%
CAGR 10-Years
-5%
Bristol-Myers Squibb Co
NYSE:BMY
Cash & Cash Equivalents
$15.7B
CAGR 3-Years
27%
CAGR 5-Years
-4%
CAGR 10-Years
15%
Pfizer Inc
NYSE:PFE
Cash & Cash Equivalents
$1.3B
CAGR 3-Years
1%
CAGR 5-Years
-3%
CAGR 10-Years
-8%
Merck & Co Inc
NYSE:MRK
Cash & Cash Equivalents
$18.2B
CAGR 3-Years
18%
CAGR 5-Years
20%
CAGR 10-Years
9%
Eli Lilly and Co
NYSE:LLY
Cash & Cash Equivalents
$9.8B
CAGR 3-Years
55%
CAGR 5-Years
22%
CAGR 10-Years
12%
No Stocks Found

Elanco Animal Health Inc
Glance View

Elanco Animal Health Inc. emerged from the hallowed halls of Eli Lilly and Company, officially standing on its own in 2018, and immediately carving out its identity as a key player in animal health. The company, headquartered in Greenfield, Indiana, prides itself on working at the intersection of science and animal well-being, bringing innovative solutions to the market. Elanco's operations revolve around two primary business segments: Companion Animal and Farm Animal. In the Companion Animal segment, the focus is squarely on developing products that improve the health and extend the lives of pets, from flea and tick treatments to vaccines that safeguard them against disease. This segment taps into the growing humanization of pets, leveraging the emotional bond between owners and animals to drive demand for premium pet healthcare products. On the other hand, Elanco's Farm Animal segment is deeply woven into the fabric of the agricultural ecosystem, serving the needs of livestock operations around the globe. This division offers a suite of products that enhance the health and productivity of cattle, swine, poultry, and aqua species, addressing concerns from disease prevention to growth efficiency. By providing antibiotics, vaccines, and other nutritional health additives, Elanco helps farmers meet the world's growing demand for protein while complying with the ever-stringent regulations on animal product safety and efficacy. The company's diversified portfolio and its global reach allow it to monetize the vast and varied animal health landscape effectively, positioning itself as a stalwart in the sector dedicated not just to animal care but to elevating the industry standards through innovation and responsible growth.

ELAN Intrinsic Value
21.1 USD
Overvaluation 11%
Intrinsic Value
Price

See Also

What is Elanco Animal Health Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
505m USD

Based on the financial report for Sep 30, 2025, Elanco Animal Health Inc's Cash & Cash Equivalents amounts to 505m USD.

What is Elanco Animal Health Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
-5%

Over the last year, the Cash & Cash Equivalents growth was 3%. The average annual Cash & Cash Equivalents growth rates for Elanco Animal Health Inc have been 3% over the past three years , -5% over the past five years .

Back to Top